Abaphandi baseNorway bavavanya umphumo we-TSH kwisifo sengqondo somngcipheko
Uphando lubonisile ukuba amaninzi e-hypothyroidism - amanqanaba e-thyroid aphantsi - kunye ne-hyperthyroidism-ephezulu ye-thyroid level - idibene nomngcipheko ophezulu we- coronary heart disease (CHD). I-CHD iyenzeka xa i-plaque yakha ngaphakathi kwimizila ye-coronary arteries, ngaloo ndlela iyanciphisa intliziyo yakho yegazi eline-oxygen. Uphando oluqhutyelwe eNorway luthathe olu phando inyathelo elinye kwaye lujonge umphumo wezinga eliqhelekileyo le-thyroid lisesengozini yokugula kwesifo senhliziyo.
Ukuhlola i-TSH ne-CHD Ingozi
Abantu abangaphezu kwama-25,000 babandakanywa kwisifundo. Abafundi abathathi-nxaxheba babekwahlula kwiinqanaba ezi-5 ezahlukeneyo ngokwe- thyroid eyenza i-hormone (TSH):
- TSH: ngaphantsi kwe-0.50
- TSH: 0.50 ukuya ku-1.4
- I-TSH: 1.5 ukuya ku-2.4
- TSH 2.5 ukuya ku-3.5
- TSH: 3.6 nangaphezulu
Ngenjongo yesifundo, uhla lwe-TSH lwesalathisi luchazwe njenge-0.50 ukuya ku-3.5 mIU / L. (Qaphela: Uluhlu lwesibonakaliso lwama-laboratories eUnited States ngokubanzi lubanzi kwaye luhamba ukusuka ku-0.50 ukuya ku-5.5mIU / L. Ukususela ngo-2002, ezinye i-endocrinologists ziye zacetyiswa ukuba inqanaba lichithwe kwi-0.30 ukuya kwi-3.0.) Ngokuqhelekileyo, I-TSH ingezantsi .50 ibonisa i-hyperthyroidism. Nantoni na ngaphezulu kwe-5.5 (kwizikhokelo eziqhelekileyo) ibonisa okanye i-hypothyroidism.
Ngethuba lokulandelwa kweminyaka engama-ezisibhozo kweso sifundo, amabhinqa angama-228 (iipesenti ezi-1.3) kunye namadoda angama-182 (iipesenti ezingama-2.3) abulawa yintliziyo yesifo senhliziyo. Kulaba bafazi abangama-192 kunye namadoda angama-164 ayenamazinga e-TSH kwisalathiso soluhlu abaphandi basebenzisa kulolu phofu.
Uluhlu lwe-0.50 ukuya ku-1.4 lwe-TSH lwalusetyenziswa njengeqela lokulawula esiseko, kwaye njengamazinga e-TSH aphakama kwimigangatho ephezulu kune-1.4, "ingozi yengozi" . (Nangona kwakukhona ukunyuka kwamadoda, kwakungekho ngokwaneleyo ukuba kuthathwa njengento ebalulekileyo.)
Uhlalutyo luphindaphindiwe kwenye into emibini yokulandelelana kamva, kwaye iziphumo zaphinde zahambelana nophando lokuqala.
Ekugqibeleni, abaphandi baphetha ukuba kukho uxhulumano olucacileyo phakathi komsebenzi ophantsi ophantsi kodwa oqhelekileyo weklinikhi kubasetyhini kunye nesifo senhliziyo esiswelekayo.
Abaphandi babika ukuba, ngolwazi lwabo, akuzange kubekho naluphi na ulingo lweekliniki ukujonga ukuba ukutshintshwa kwe-hormone ye-thyroid kunokunceda ukukhusela kwisifo senhliziyo. Kodwa-ke, baqaphele ukuba olunye uphando lubonise ukuba unyango lwe-hormone ye-thyroid luya kuphucula amazinga e-cholesterol, ukuphucula umsebenzi wokugqibela (umlinganiselo wesifo se-vascular) nokunciphisa ezinye iimpawu ze-atherosclerosis.
Kuthetha ukuthini oku kuLuntu?
Ngokuqinisekileyo, ezi ziphumo zenza ukuba kubaluleke ngakumbi ukuba kwenziwe izifundo ezongezelelweyo zesini, ngenjongo yokugqiba ukuba i-hormone ye-thyroid ibe yindawo yabantu abangama-TSH angaphezu kwe-1.4 iya kunciphisa ingozi ye-heart disease coronary disease.
Izifundo ezongezelelweyo ziza kuba zibaluleke kakhulu kuba besetyhini banakho amathuba okuphuhlisa izifo ze-thyroid kunye nesifo senhliziyo kukubanga lokufa kwabasetyhini.
Njengoko sele sisazi ukuba i-hormone yokutshintshwa kwe-thyroid ingakwazi ukuphucula amanqaku ahlukahlukeneyo kwisifo senhliziyo, kukho ubungqina obuninzi bokuthi i-endocrinology kunye noluntu lwebhoratri kufuneka ekugqibeleni lifike kwisivumelwaniso malunga nokuthobela uluhlu oluthile olubhekiselele.
Ukunciphisa ulwahlulo lwesalathisi kunokunceda abantu bafikelele imithi ye-thyroid kungekudala.
Umthombo:
Åsvold, uBjørn MD; et. al. "Izinga le-Thyrotropin kunye neengozi yeCatalon Heart Heart Disease: I-HUNT Study," Arch Intern Med. 2008; 168 (8): 855-860.